Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

Using low doses of esketamine to improve sleep quality after breast cancer surgery

Official title: Effect of Subanesthetic Dose of Esketamine on Sleep Quality in Patients With Breast Cancer After Chemotherapy

Run by Nanjing First Hospital, Nanjing Medical University · NCT06773143 · Data updated 2026-11-12

This study is testing whether low doses of esketamine can help improve sleep quality for people recovering from breast cancer surgery.

More Insomnia trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment184 (estimated)
SponsorNanjing First Hospital, Nanjing Medical University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedDecember 30, 2024
Main results expectedDecember 31, 2026
Study endsApril 30, 2027
Registry record updatedFebruary 10, 2025
Trial IDNCT06773143 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 65 with a diagnosis of breast cancer who are receiving neoadjuvant chemotherapy.

Probably not a fit

Patients with a BMI over 30, cognitive dysfunction, or severe organ dysfunction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of subanesthetic doses of esketamine on sleep quality in patients undergoing modified radical mastectomy for breast cancer. A total of 184 participants will be enrolled, and their sleep quality will be assessed using various scales before and after surgery. The study aims to understand how esketamine can mitigate postoperative sleep disturbances, which are common in patients undergoing surgery after neoadjuvant chemotherapy. Blood samples will also be collected to analyze potential biomarkers related to sleep and inflammation.

Why it matters

Potential benefit: If successful, this study could significantly improve sleep quality and recovery outcomes for breast cancer patients undergoing surgery.

How similar studies have gone: While the use of esketamine for sleep disturbances is a novel approach, similar studies have shown promising results in managing postoperative pain and anxiety.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients diagnosed with breast cancer by pathology and immunohistochemistry
2. Patients receiving neoadjuvant chemotherapy
3. Age 18 to 65 years old; d) ;
4. ASA grade Ⅰ - Ⅲ
5. BMI 18 to 30 kg/m2

Exclusion Criteria:

* 1: Patients refuse to participate in the study

  2: BMI \> 30 kg/m2

  3: Recent history of drug abuse

  4: Allergy to or contraindications to esketamine

  5: Cognitive dysfunction or inability to communicate

  6: Severe dysfunction of important organs such as liver and kidney function

Where it's running

  • Nanjing First Hospital
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.